Market Overview

Dr. Reddy's Laboratories Ltd (NYSE: RDY)

42.43 +1.21 (2.94%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/09/20CitigroupUpgradesBuy
11/04/19Bank of AmericaDowngradesNeutral
9/04/19Credit SuisseUpgradesOutperform
6/11/19BarclaysInitiates Coverage OnEqual-Weight39.0
5/20/19Morgan StanleyDowngradesEqual-Weight
11/01/17JefferiesMaintainsUnderperform30.5
9/21/17Morgan StanleyUpgradesOverweight
7/27/16HSBCDowngradesReduce
7/27/16JefferiesDowngradesUnderperform
7/26/16Credit SuisseDowngradesUnderweight

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter